Key facts
| Price (PPV) | 3,480 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | denosumab |
| Class | Drugs for treatment of bone diseases |
| ATC code | M05BX04 |
| Manufacturer | SOTHEMA |
| Presentation | Boite de 1 flacon de 1.7 ml |
| Hospital price | 3,170 MAD |
| Data collected on | 9/8/2026 |
Indications
Prévention des complications osseuses (fractures pathologiques, irradiation osseuse, compression médullaire ou chirurgie osseuse) chez des patients adultes présentant une affection maligne avancée avec atteinte osseuse. Traitement des adultes et des adolescents à maturité squelettique atteints de tumeurs osseuses à cellules géantes, non résécables ou pour lesquels la résection chirurgicale est susceptible d’entraîner
Find an open pharmacy
On-call pharmacies near you
About Xgeva 120 mg
Xgeva 120 mg belongs to the drugs for treatment of bone diseases therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Xgeva 120 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Xgeva 120 mg
Answers to common questions from Moroccan patients about this drug.